By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Puma Biotechnology 

10940 Wilshire Boulevard
Suite 600
Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


Company News
Puma Biotech (PBYI) Reports Second Quarter 2017 Financial Results 8/10/2017 7:16:47 AM
Puma Biotech (PBYI) Receives Day-180 List Of Outstanding Issues From Committee For Medicinal Products For Human Use (CHMP) 8/3/2017 8:01:24 AM
Puma Biotech (PBYI) Announces Availability Of NERLYNX™ (Neratinib) For Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer In The United States 8/1/2017 7:58:31 AM
Puma Biotech (PBYI) Surges After the FDA Officially Approves Breast Cancer Drug 7/18/2017 5:53:26 AM
Puma Biotech (PBYI) Completes Targeted Enrollment In Neratinib Phase III Metastatic Breast Cancer Trial 7/7/2017 7:04:39 AM
Genentech (RHHBY)’s Perjeta-Based Adjuvant Breast Cancer Care Shows Minor Improvement, Puma Biotech (PBYI) Shares Jump 6/6/2017 6:26:19 AM
Puma Biotech (PBYI) Announces Positive PB272 Phase II Data From TBCRC 022 Trial In Patients With HER2-Positive Metastatic Breast Cancer With Brain Metastases At The 2017 ASCO Annual Meeting 6/5/2017 10:38:23 AM
Puma Biotech (PBYI) Gets A Leg Up As Genentech (RHHBY) Suffers Blow Over Breast Cancer Combo Therapy 6/5/2017 6:42:56 AM
Puma Biotech (PBYI) Receives FDA Advisory Committee Support For Neratinib 5/26/2017 6:49:31 AM
Puma Biotech (PBYI) Receives FDA Advisory Committee Support For Neratinib 5/25/2017 6:45:25 AM